Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS
Status:
Recruiting
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
The primary objective of this randomized controlled clinical trial in a real life setting is
to evaluate the cost-utility of limumab monotherapy compared with the combination of
adalimumab and a maximum of three surgeries after two years of treatment in adult patients
with moderate to severe HS.